N. Johnson

IL‐8/IL‐8 receptor expression in psoriasis and the response to systemic tacrolimus (FK506) therapy

A. Thomson, A. Nikaein, B. Lemster, 1995, Clinical and experimental immunology.

Influence of FK 506 (tacrolimus) on circulating CD4+ T cells expressing CD25 and CD45RA antigens in 19 patients with chronic progressive multiple sclerosis participating in an open label drug safety trial.

W. Irish, J. Fung, K. Abu-Elmagd, 1994, Autoimmunity.

Effect of tacrolimus (FK506) in dystrophic epidermolysis bullosa: rationale and preliminary results.

D. V. van Thiel, T. Starzl, B. Jegasothy, 1994, Archives of dermatology.

Changes in quality of life following conversion from CyA to FK 506 in orthotopic liver transplant patients.

T. Starzl, J. Fung, A. Jain, 1991, Transplantation proceedings.